Romy M Heilmann Selected Research

Leukocyte L1 Antigen Complex (Calgranulin)

5/2022	Associations among serum insulin, calprotectin, and C-reactive protein concentrations in Miniature Schnauzers with idiopathic hyperlipidemia before and after feeding an ultra-low-fat diet.
1/2021	Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs.
7/2019	Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome.
3/2019	Association of serum calprotectin (S100A8/A9) concentrations and idiopathic hyperlipidemia in Miniature Schnauzers.
9/2018	Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.
3/2018	Preanalytical validation of an in-house radioimmunoassay for measuring calprotectin in feline specimens.
3/2018	Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies.
9/2017	Fecal markers of inflammation, protein loss, and microbial changes in dogs with the acute hemorrhagic diarrhea syndrome (AHDS).
1/2015	Inflammatory, immunological, and intestinal disease biomarkers in Chinese Shar-Pei dogs with marked hypocobalaminemia.
1/2014	Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Romy M Heilmann Research Topics

Disease

19	Inflammation (Inflammations) 01/2021 - 12/2010
13	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 12/2011
7	Diarrhea 01/2022 - 01/2012
3	Neoplasms (Cancer) 04/2019 - 01/2014
2	Hyperlipidemias (Hyperlipidemia) 05/2022 - 03/2019
2	Exocrine Pancreatic Insufficiency 11/2021 - 08/2013
2	Body Weight (Weight, Body) 01/2021 - 10/2013
2	Infections 01/2021 - 01/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020 - 12/2019
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2019 - 11/2017
2	Sepsis (Septicemia) 07/2019 - 11/2017
2	Dysbiosis 09/2018 - 09/2017
2	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 09/2018 - 01/2015
1	Hypokalemia 01/2022
1	Wasting Syndrome (Wasting Disease) 01/2022
1	IgA Deficiency 11/2021
1	Liver Diseases (Liver Disease) 10/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Histoplasmosis 05/2021
1	Obesity 01/2021
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Foreign Bodies (Foreign Body) 04/2019
1	Rhinitis 04/2019
1	Aspergillosis 04/2019
1	Nose Diseases (Disease, Nose) 04/2019
1	Hypercholesterolemia 03/2019
1	Hypertriglyceridemia 03/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Virus Diseases (Viral Diseases) 01/2018
1	Gastrinoma 11/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2017
1	Pathologic Complete Response 09/2016
1	Abscess 01/2016
1	Ulcerative Colitis 12/2015
1	Crohn Disease (Crohn's Disease) 12/2015
1	Intestinal Diseases (Diseases, Intestinal) 01/2015
1	Mucinoses 01/2015
1	Transitional Cell Carcinoma 01/2014
1	Urinary Tract Infections (Urinary Tract Infection) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Bacteremia 12/2013
1	Hyperhomocysteinemia 08/2013

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 12/2019 - 12/2012
18	S100A12 ProteinIBA 01/2021 - 12/2010
14	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2022 - 12/2012
6	Proteins (Proteins, Gene)FDA Link 03/2019 - 12/2011
5	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2021 - 08/2013
4	C-Reactive ProteinIBA 05/2022 - 12/2012
3	Immunoglobulin A (IgA)IBA 11/2021 - 01/2014
3	Peptide Hydrolases (Proteases)FDA Link 09/2018 - 09/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2019 - 09/2016
2	CytokinesIBA 09/2018 - 12/2015
2	Advanced Glycation End ProductsIBA 09/2018 - 10/2014
2	ChemokinesIBA 09/2018 - 12/2015
2	Peroxidase (Myeloperoxidase)IBA 04/2018 - 09/2015
2	Pattern Recognition ReceptorsIBA 11/2017 - 10/2014
2	Calcium-Binding ProteinsIBA 03/2016 - 01/2014
2	AlbuminsIBA 01/2016 - 01/2015
2	Volatile Fatty AcidsIBA 10/2013 - 01/2012
1	Insulin (Novolin)FDA Link 05/2022
1	Glutens (Glutelin)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	ElectrolytesIBA 01/2022
1	TriazolesIBA 05/2021
1	Itraconazole (Sporanox)FDA LinkGeneric 05/2021
1	CreatinineIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 04/2019
1	Temazepam (Nocturne)FDA LinkGeneric 04/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	N-methylhistamineIBA 09/2018
1	bromotyrosineIBA 09/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2018
1	Methylmalonic AcidIBA 09/2018
1	AntibodiesIBA 09/2018
1	Alkaline PhosphataseIBA 09/2018
1	GastrinsIBA 11/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Immunoglobulin M (IgM)IBA 01/2015
1	ZincIBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 01/2015
1	Hyaluronic Acid (Hyaluronan)IBA 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 10/2014
1	AmmoniaIBA 10/2013
1	EnzymesIBA 08/2013
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 08/2013
1	Methylmalonyl-CoA MutaseIBA 08/2013
1	GlucocorticoidsIBA 12/2012
1	16S Ribosomal RNAIBA 01/2012

Therapy/Procedure

4	Therapeutics 05/2021 - 12/2013
2	Fat-Restricted Diet (Diet, Fat Restricted) 05/2022 - 03/2019
2	Aftercare (After-Treatment) 01/2019 - 01/2018